Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - REVENUE
Revenue NTLA - Intellia Therapeutics, Inc.
36.3 M
LAST VALUE
4.76%
2 YEAR CAGR
3.57%
5 YEAR CAGR
0.00%
10 YEAR CAGR